FDA panel recommends approval of Visian toric implantable collamer lens, has reservations

GAITHERSBURG, Md. – The Visian toric implantable collamer lens was today recommended for approval by the Ophthalmic Devices Panel of the Medical Devices Advisory Committee of the U.S. Food and Drug Administration. The Visian toric implantable collamer lens (TICL, STAAR Surgical) is a toric model intended for the correction of myopic astigmatism in adults age 21 to 45 years. Majority ruled in favor of recommending the lens be approved on all three questions posed to the panel.

Full Story →